No Data
No Data
Ability Biologics Anuncia El Cierre De Su Extensión De Financiación Inicial De 18 Millones De Dólares
- Ability Biologics anuncia el cierre de su extensión de financiación inicial de 18 millones de dólares para la generación de inmunomoduladores novedosos y altamente específicosMONTREAL, 18 de j
Ability Biologics Announces the Closing of Its US $18 Million Seed Funding Extension Toward the Generation of Novel, Highly Targeted Immunomodulators
MONTREAL, June 18, 2024 /PRNewswire/ -- Ability Biologics ("Ability") announced the final closing of its seed funding, raising a total of $18 million (US), a financing round led by founding investor
Express News | Amplitude Announced Six Expanded Integrations For Businesses
Amplitude Expands Partner Ecosystem to Help Companies Build Better Products
New integration portal enables partners to quickly and easily build on the Amplitude platform Today, Amplitude, Inc. (NASDAQ:AMPL), a leading digital analytics platform, announced six new and expanded integrations
Amplitude Brings the Power of Product Analytics to Snowflake AI Data Cloud
New offering helps companies uncover complete customer insights without any data leaving the AI Data Cloud Today at Snowflake Data Cloud Summit 2024, Amplitude, Inc. (NASDAQ:AMPL) announced the general availability of
This Amplitude Insider Reduced Their Stake By 100%
Insiders were net sellers of Amplitude, Inc.'s (NASDAQ:AMPL ) stock during the past year. That is, insiders sold more stock than they bought. Although we don't think shareholders should simply foll
No Data